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Abstract
Background: Certain conditions characterised by blood vessel occlusion or vascular spasm have
been found to cluster together in epidemiological studies. However the biological causes for these
associations remain controversial. This study used a classical twin design to examine whether these
conditions are linked through shared environmental exposures or by a common underlying genetic
propensity to vasospasm.
Methods:  We investigated the association between hypertension, migraine, Raynaud's
phenomenon and coronary artery disease in twins from a national register. Phenotype status was
determined using a questionnaire and the genetic and environmental association between
phenotypes was estimated through variance components analysis.
Results: Responses were obtained from 2,204 individuals comprising 525 monozygotic and 577
dizygotic pairs. There was a significant genetic contribution to all four traits with heritabilities
ranging from 0.34 to 0.64. Multivariate model-fitting demonstrated that a single common genetic
factor underlies the four conditions.
Conclusions: We have confirmed an association between hypertension, migraine, Raynaud's
phenomenon and coronary artery disease, and shown that a single genetic factor underlies them.
The demonstration of a shared genetic factor explains the association between them and adds
weight to the theory of an inherited predisposition to vasospasm.
Background
A number of conditions characterised by blood vessel
occlusion and/or vascular spasm have been found to be
associated in both clinical and epidemiological studies.
These include hypertension (HPT), Raynaud's phenome-
non (RP), migraine (MIG) and coronary artery disease
(CAD) [1-5]. Whether these associations are the conse-
quences of a shared environmental risk factor or represent
an underlying propensity to develop the conditions
through a common biological mechanism remains con-
troversial. The exploration of the genetic and environmen-
tal relationships underlying these conditions is one
approach to resolving the biological basis for the associa-
tion. We have examined the association between these
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phenotypes in a classical twin study conducted in a large
sample. This approach allows us to assess whether the
association between HPT, RP, MIG and CAD is explained
by a common genetic or environmental aetiology.
Methods
Subjects and methods
Subjects for this study were twins enlisted with the St Tho-
mas' UK Adult Twin Registry [6]. These monozygotic
(MZ) and dizygotic (DZ) twin volunteers have been
recruited since 1992 using twin registers and successive
national media campaigns. For historical reasons most
enrolled twins are female. This well studied population is
sent regular questionnaires for self-completion concern-
ing a wide range of health issues. Questions relating to
HPT, MIG, RP and CAD respectively were contained
within large questionnaires sent to the twins in 1998 and
2000. The questions were non-consecutive and respond-
ents were unaware of the hypothesis being tested. The
questionnaires also included standard questions relating
to zygosity assignment [7]. In addition, fifty-four percent
of the respondents had their zygosity assigned with cer-
tainty by multiplex DNA fingerprinting using variable tan-
dem repeats on samples taken on previous attendances at
the Twin Unit.
Classification of HPT, RP, MIG AND CAD
Classification of the traits HPT, RP, MIG and CAD was
based on standard, validated criteria where possible. HPT
was classified by asking about a doctor's diagnosis of
"high blood pressure" when not pregnant. Questions to
determine presence of migraine were based on the UCSD
Migraine Questionnaire [8] (including at least five epi-
sodes of unilateral, pulsating headache over the previous
year, duration four to seventy-two hours, noise and light
sensitivity). RP was classified by confirming digital sensi-
tivity to cold and required the respondent to have had
recurrent episodes of colour change involving at least two
colours [9]. CAD was classified either by respondents hav-
ing a doctor's diagnosis of heart disease or angina, a pre-
vious heart attack or heart operation; or by answering
affirmatively to questions taken from the Rose Angina
questionnaire [10].
Analysis
Traits were defined categorically as present or absent using
the definitions listed above. Phenotypic associations
between the four traits were assessed using odds ratios and
95% confidence intervals (CI) corrected to take into
account the paired nature of the data. The odds ratios were
adjusted for possible confounding by age, smoking and
body mass index (BMI). Evidence for a genetic contribu-
tion to each trait was examined by estimating casewise
concordance [11]. This measures the probability that the
co-twin of an affected twin also expresses the trait. Higher
casewise concordance in MZ pairs compared to DZ twin
pairs indicates a genetic effect.
Where data suggested a genetic influence, a quantitative
measure of genetic contribution was estimated using
structural equation modelling (Mx software [12]). This
standard approach to twin analysis assumes an underly-
ing model in which the observed phenotypic correlation
among twins is explained by latent additive genetic influ-
ences (A) (which have a correlation of 1 in MZ twins and
0.5 in DZ twins), common environmental influences (C)
(having a correlation of 1 in both MZ and DZ twins) and
the random environment (E) (uncorrelated among
twins). Analysis proceeds on the assumption that the
observed categorical phenotype is accounted for by a con-
tinuous underlying liability to the trait [13]. Correlation
in underlying liability is used as the basis for measuring
the association between variables in the modeling. The
significance of shared genetic and environmental factors
was tested by stepwise deletion in a sequence of models
containing the variance components (A, C and E) and
assessing the deterioration in chi-squared for the fit of the
model. Heritability was estimated from the size of the
additive genetic contribution to the final selected model.
Modeling was then extended to consider the genetic and
environmental associations between all four variables
simultaneously [13]. Three multivariate models were
considered:-
(1) the Cholesky decomposition (Figure 1) which
includes four independent genetic and environmental fac-
tors. The first factor loads on all the traits, the second fac-
tor loads on all traits except the first, the third loads on all
traits except the first two etc. This provides the fullest
potential explanation of the data
(2) the independent pathway model (Figure 2) is a sub-
model of the Cholesky model and considers the data to be
explained by a single shared genetic and shared environ-
mental factor
(3) the common pathway model (Figure 3) which consid-
ers a single shared latent phenotype, determined in turn
by latent genetic and environment factors.
The suitability of the common and independent pathway
models may be determined by comparing the model's
Akaike information criterion (AIC) with that of the fullest
model, the Cholesky. The AIC represents the balance
between model fit and the number of parameters (parsi-
mony), with lower values of AIC indicating the most suit-
able model. Parameter estimates from the most
appropriate model were used to calculate the genetic and
environmental correlation between variables.BMC Cardiovascular Disorders 2004, 4:20 http://www.biomedcentral.com/1471-2261/4/20
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The Cholesky AE model Figure 1
The Cholesky AE model. Diagram representing the Cholesky AE model, in which additive genetic (A) effects are shown loading 
on to the four traits: the unique environment (E) would load similarly
The independent AE pathway model Figure 2
The independent AE pathway model. Diagram of the independent AE pathway, in which a single genetic and single unique envi-
ronment factor loads on to each of the four traits, as well as factors specific to each traitBMC Cardiovascular Disorders 2004, 4:20 http://www.biomedcentral.com/1471-2261/4/20
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The common pathway model Figure 3
The common pathway model. Diagram of the common factor pathway in which single genetic and unique environment factors 
load on to the traits via a phenotypic latent variable
Table 1: Prevalence of the traits by zygosity and the p value of the difference between zygosities
trait MZ prevalence (%) n = 1050 DZ prevalence (%) n = 1154 p
HPT 131 (12.5) 181 (15.7) 0.052
RP 111 (10.6) 131 (11.4) 0.584
MIG 264 (25.1) 266 (23.1) 0.290
CAD 71 (6.8) 76 (6.6) 0.873
n represents number of twins, MZ monozygotic, DZ dizygotic, HPT hypertension, RP Raynaud's phenomenon, MIG migraine, CAD coronary artery 
disease
Table 2: Odds ratios (95% confidence interval) of unadjusted and adjusted (for age, smoking and BMI) cross-trait associations





MIG 1.31 (0.99–1.73) 1.62 (1.21–2.17)
adj 1.31 (0.95–1.80) 1.68 (1.23–2.3)
CAD 2.85 (1.96–4.16) 2.03 (1.29–3.17) 2.19 (1.53–3.13)
adj 2.41 (1.56–3.73) 2.27 (1.42–3.65) 1.77 (1.19–2.63)
Calculation of odds ratios included a correction factor for familial clustering. Unadjusted odds ratios are shown above and adjusted below, for each 
combination of phenotypes. BMI represents body mass index, HPT hypertension, RP Raynaud's phenomenon, MIG migraine, CAD coronary artery 
disease.BMC Cardiovascular Disorders 2004, 4:20 http://www.biomedcentral.com/1471-2261/4/20
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Results
Complete data for analysis were available from 1,102
pairs of female twins, comprising 525 MZ and 577 DZ
pairs. The mean (± SD) age of the twins was 48.5 (± 8.2)
years. The prevalence of each trait is shown in Table 1.
Four of the six combinations of traits showed significant
phenotypic association after adjusting for age, smoking
and BMI (odds ratios, Table 2). HPT was clearly not asso-
ciated with RP but there was a suggestion of association of
HPT with migraine (significantly so if adjusted for age and
smoking only, data not shown). Since smoking status, age
and BMI did not influence the size of the odds ratios,
these variables were not included in the multivariate mod-
eling. Concordance data and the results of univariate
modeling confirmed a significant heritable component to
all 4 traits (Table 3). Multivariate model fitting showed
that for each of the three models tested, a model
containing genetic (A) and unique environmental (E) fac-
tors provided the best explanation of the data (Table 4, in
bold): incorporation of a shared environmental factor (C)
offered no significant improvement in the fit of any
model. The independent AE pathway model (Figure 2)
offered the best explanation of the data, suggesting that a
single common genetic factor loads on the four traits HPT,
RP, migraine and CAD. A unique environmental factor
Table 3: Casewise concordance rates by zygosity and heritability estimates of the four traits








HPT MZ 525 73 29 0.44 (0.34–0.55) 0.64 (0.49–0.79)
DZ 577 135 23 0.25 (0.17–0.34)
RP MZ 525 75 18 0.32 (0.21–0.44) 0.46 (0.30–0.63)
DZ 577 111 10 0.15 (0.07–0.24)
MIG MZ 525 144 60 0.46 (0.38–0.53) 0.43 (0.30–0.55)
DZ 577 186 40 0.30 (0.23–0.37)
CAD MZ 525 55 8 0.23 (0.10–0.35) 0.34 (0.13–0.55)
DZ 577 72 2 0.05 (0.00–0.12)
Casewise concordance rates (95% confidence intervals, CI) are shown for each trait by zygosity. An estimate of trait heritability (95% CI) is also 
given.
HPT represents hypertension, RP Raynaud's phenomenon, MIG migraine, CAD coronary artery disease.
Table 4: Results of the model fitting: comparison of the 3 models
model chi2 df p AIC
CHOLESKY ACE 32.95 30 0.33 -27.05
AE 33.35 40 0.76 -46.65
CE 65.82 40 0.01 -14.18
INDEPENDENT ACE 38.98 36 0.34 -33.02
AE 40.82 44 0.61 -47.18
CE 72.03 44 0.01 -15.97
COMMON FACTOR ACE 49.68 42 0.19 -34.32
AE 49.68 47 0.38 -44.32
CE 81.49 47 0.00 -12.51
For each submodel, the chi2 statistic, the degrees of freedom (df) the probability (p) and the Akaike information criterion (AIC) are shown. AIC is 
used to evaluate the fit, with the best fitting submodel shown in bold in each case.
Table 5: Genetic correlations (bold type, below in table) and 
unique environmental correlations (above) of the traits
HPT RP MIG CAD
HPT 0.29 0.01 0.17
RP 0.20 0.00 0.05
MIG 0.23 0.36 0.00
CAD 0.35 0.56 0.65
HPT represents hypertension, RP Raynaud's phenomenon, MIG 
migraine, CAD coronary artery diseaseBMC Cardiovascular Disorders 2004, 4:20 http://www.biomedcentral.com/1471-2261/4/20
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loads similarly on the traits. Using this model, genetic and
unique environmental correlations between the four traits
were calculated (Table 5). Overall, the genetic correlations
were greater than the environmental correlations, suggest-
ing a greater role for the genetic factor than the unique
environmental factor.
Discussion
This is the first study to examine the role of genetic and
environmental factors in explaining the association
between HPT, RP, migraine and CAD. The results suggest
that all four variables share a heritable basis. These condi-
tions have been shown to be associated with one another
and individually each is known to have a genetic basis.
The data presented here confirm these previous findings
and suggest that shared environmental factors such as diet
and lifestyle do not contribute to their expression. In view
of the nature of these phenotypes, we speculate that the
shared genetic component leads to a predisposition to
vasospasm. Indeed, a 'vasospastic phenotype' to account
for their co-occurrence has been postulated by others [14].
The demonstration of a single genetic component lends
weight to such a theory.
A number of considerations should to be taken into
account when interpreting these results. Self administered
questionnaires were used for trait ascertainment,
introducing the possibility of recall bias. In the present
study efforts were taken to minimise recall bias: when sur-
veyed, the twins were unaware of the hypothesis being
tested; the questions relating to vascular phenotypes were
included non-sequentially and were amongst many other
questions in two questionnaires mailed at different times;
and the twins completed questionnaires separately with
no knowledge of their co-twin's responses. Furthermore
there is no reason to suspect differential rates of recall in
MZ when compared to DZ twins, hence any effects of
recall should not have biased our estimates of genetic
influence. Some conditions, such as RP, are notoriously
difficult to diagnose regardless of the method employed
[15] and it is possible that some subjects have cardiac
valve rather than coronary artery disease. No attempt was
made to differentiate primary RP and essential HPT from
their secondary forms. However, questionnaire diagnoses
were based on standard methods [8-10]. Despite these
limitations, the traits' prevalences are in keeping with the
findings of others for RP (9.6%[3], 5% and 16.8% accord-
ing to geographical area sampled [16]), migraine (20%
[17]) and CAD (8% [18]). In addition, heritability esti-
mates are consistent with published findings for MIG
(49–58% [19]), blood pressure (40–70% [20], 57% [21])
and CAD (15–30% [18]). Taken together, these observa-
tions suggest that our twins are representative of the adult
female population and do not simply reflect a 'healthy
volunteer' sample.
The assumptions underpinning twin studies themselves
may be questioned. Unequal sharing of the family envi-
ronment by MZ and DZ twins has been raised as a con-
cern, but this has been shown not to be the case [22]. In
addition, twins from this cohort have been shown to be
similar to singletons with respect to anti-hypertensive
drug use, blood pressure and other phenotypes [23]. The
proposed inverse relationship between birth weight and
HPT [24] and CAD [25] could potentially bias a study of
twins and cardiovascular disease. The explanation for this
relationship is still debated, but maternal environment
has been suggested to be the main influence on adult
blood pressure [26]. As we have demonstrated that the
shared environment makes no significant contribution to
the vasospastic phenotype, this is not a likely source of
error.
It is clear that genetic factors play an important role in all
four conditions. The demonstration that they are heritable
is consistent with numerous reports of clustering in twin
and family studies conducted in a range of settings,
including a Dutch kindred with an autosomal dominant
condition characterised by vascular retinopathy, migraine
and Raynaud's phenomenon [27]. The detection of a
common, genetically determined mechanism that con-
tributes to these conditions is important because it points
to an intermediate phenotype, vasospasm, and provides a
possible focus for future studies. As with all chronic dis-
eases and traits, the difficulty is in establishing which
genes are responsible. Vascular tone is controlled at many
levels, including local soluble mediators and
neurotransmitters. Genes proposed through the study of
the individual phenotypes include the beta2-adrenergic
receptor gene in hypertension [28]; the muscle acetylcho-
line- and serotonin receptor genes in RP [29]; and a G pro-
tein subunit polymorphism and endothelial nitric oxide
gene polymorphism in CAD [30]. A gain of function
mutation in a vasoconstrictor or a loss of function muta-
tion in a vasodilator may predispose to vasospasm: many
of these genes deserve further consideration with the iden-
tification of a common genetic factor underlying HPT,
migraine, RP and CAD.
In summary, this twin study has identified phenotypic
associations between four vascular conditions and shown
that the association is explained by a single common
genetic factor. These findings are consistent with the pro-
posed 'vasospastic phenotype' and suggest that studies of
genes controlling vascular tone will help to define the
genetic basis of these conditions.
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